Financial profile · Q3 FY2026

An asset-heavy hospital operator with thin margins and debt-sensitive earnings

Across the multi-year record, revenue has stayed in a relatively narrow range, while operating income provides a limited cushion over substantial financing costs, leaving common earnings sensitive to tax and divestiture items. Recurring capital spending and working-capital swings make cash conversion uneven rather than reliably tracking earnings.

What is developing

Latest trailing results show lower revenue and operating income alongside negative free cash flow, even as capital spending remained close to its prior-year level. This is a meaningful weakening within an already variable cash-conversion pattern, not clear evidence that the underlying financial model has changed.

What matters next

Whether trailing operating cash flow again covers capital spending as patient receivables cease to absorb cash.

USD
Metric FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
(1.6B) (2.4B) (704m) (590m) 607m 368m 179m 16m (362m) 676m
1.1B 861m 700m 608m 558m 540m 534m 505m 486m 426m
(116m) (454m) (3m) 203m (187m) 170m 165m 35m (116m) (243m)
46m 24m 13m 10m 13m 25m 20m 22m 17m 11m
2B 2.2B 699m 435m (21m) 167m (99m) 44m 481m (319m)
16m (4m) 19m 3m (2m) 4m 6m 91m 171m 249m
930m 852m 936m 1B 1B 778m 835m 801m 741m 804m
(177m) 525m (418m) (271m) 1.2B (1.4B) (479m) (390m) (9m) 3m
1.1B 773m 274m 385m 2.2B (131m) 300m 210m 480m 543m
(744m) (564m) (527m) (438m) (440m) (469m) (415m) (467m) (360m) (335m)
1.4B 1.6B 282m 436m 617m (55m) 156m 441m 85m 1.2B
630m 1.1B (245m) (2m) 177m (524m) (259m) (26m) (275m) 847m
(6m) (5m) (1m) (1m) (1m) (5m) (8m) (4m) (1m) (2m)
(1.7B) (1.3B) (175m) (276m) (638m) (56m) (231m) (120m) (39m) (984m)
22m (167m) (220m) (86m) (256m) (453m) (191m) (140m) (166m) (181m)
(1.7B) (1.5B) (396m) (363m) (895m) (514m) (430m) (264m) (206m) (1.2B)
54m 325m (367m) 20m 1.5B (1.2B) (389m) (80m) (1m) 223m
393m 209m (253m) (53m) 1.7B (600m) (115m) (257m) 120m 208m